Citadel Advisors - ALTAMIRA THERAPEUTICS LTD ownership

ALTAMIRA THERAPEUTICS LTD's ticker is and the CUSIP is G0360L100. A total of 16 filers reported holding ALTAMIRA THERAPEUTICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ALTAMIRA THERAPEUTICS LTD
ValueSharesWeighting
Q3 2022$30,000
+57.9%
104,120
+161.6%
0.00%
Q2 2022$19,000
-82.7%
39,800
-60.3%
0.00%
Q1 2022$110,000
+29.4%
100,200
+112.7%
0.00%
Q4 2021$85,000
-26.7%
47,100
-18.2%
0.00%
Q3 2021$116,00057,5720.00%
Other shareholders

There were no reported owners of ALTAMIRA THERAPEUTICS LTD in Q3 2022.

NameSharesValueWeighting ↓
View complete list of ALTAMIRA THERAPEUTICS LTD shareholders